-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIDGEBIO ONCOLOGY THERAPEUTICS INC : LEERINK PARTNERS CUTS TARGET PRICE TO $27 FROM $39

Reuters·09/10/2026 10:48:17

Please log in to view news